These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8879626

  • 1. Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF.
    Mitterer M, Hirber J, Gentilini I, Prinoth O, Fabris P, Emmerich B, Coser P, Straka C.
    Bone Marrow Transplant; 1996 Sep; 18(3):611-7. PubMed ID: 8879626
    [Abstract] [Full Text] [Related]

  • 2. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA, Garcia-Sanchez F, Lillo R, Vicent MG, Vicario JL, Madero L.
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [Abstract] [Full Text] [Related]

  • 3. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.
    Murea S, Goldschmidt H, Hahn U, Pförsich M, Moos M, Haas R.
    J Clin Apher; 1996 Jan; 11(4):185-94. PubMed ID: 8986864
    [Abstract] [Full Text] [Related]

  • 4. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 5. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jérusalem G, Bours V, Bosquée L, Schaaf-Lafontaine N, Paulus JM, Sondag D, Fillet G, Beguin Y.
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F, Cavenaghi L, de Melo CM.
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [Abstract] [Full Text] [Related]

  • 7. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 8. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G, Patoia L, Giglietti A, Alessio M, Pelicci P, Grignani F.
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [Abstract] [Full Text] [Related]

  • 9. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
    Kröger N, Zeller W, Hassan HT, Krüger W, Gutensohn K, Löliger C, Zander AR.
    Bone Marrow Transplant; 1999 Jan; 23(2):125-9. PubMed ID: 10197796
    [Abstract] [Full Text] [Related]

  • 10. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 11. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 12. [Effect of processed blood volume, leukocyte count and concentration of CD34-positive cells in peripheral blood on efficiency of stem cell apheresis].
    Matic GB, Ullrich H, Barlage S, Rothe G, Schmitz G.
    Beitr Infusionsther Transfusionsmed; 1997 Mar; 34():139-43. PubMed ID: 9417337
    [Abstract] [Full Text] [Related]

  • 13. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 14. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
    Delamain MT, Metze K, Marques JF, Reis AR, De Souza CA, Lorand-Metze I.
    Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
    [Abstract] [Full Text] [Related]

  • 15. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF, Suryadevara U, Pereyra V, Colón D, Fontelonga A, Mackintosh FR, Hall SW, Ascensão JL.
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [Abstract] [Full Text] [Related]

  • 16. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
    Alegre A, Tomás JF, Martínez-Chamorro C, Gil-Fernández JJ, Fernández-Villalta MJ, Arranz R, Díaz MA, Granda A, Bernardo MR, Escudero A, López-Lorenzo JL, Fernández-Rañada JM.
    Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, Masia CM, Centurioni R, Mancini S, Brunori M, Leoni P.
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [Abstract] [Full Text] [Related]

  • 18. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.
    de Fabritiis P, Gonzalez M, Meloni G, De Propris MS, Bellucci R, Cordone I, Gozzer M, Leone G, Mandelli F.
    Bone Marrow Transplant; 1999 Jun; 23(12):1229-36. PubMed ID: 10414908
    [Abstract] [Full Text] [Related]

  • 19. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J, Moraleda JM, Ortuño F, Lozano ML, Ayala F, Vallejo C, de Arriba F, Vicente V.
    Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
    [Abstract] [Full Text] [Related]

  • 20. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J, Filip S, Medková V, Bláha M, Mericka P, Volenec K.
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.